Altogether, our findings reveal a SOX10‐DEPDC1B‐SCUBE3 regulatory axis that promotes melanoma angiogenesis and facilitates its metastatic progression, suggesting the possibility of targeting secreted SCUBE3 as a therapeutic strategy against metastatic melanoma. Here, SOX10 is linked to metastatic melanoma.